Skip to main content

Find Clinical Trials

Clinical trial condition

NSCLC

Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.

367 public trials 125 recruiting studies

Refine in advanced search Browse all conditions

NSCLC trial results

Recruiting

TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases

NCT05948813

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +8 more
Locations: National Cancer Center/Cancer Hospitial,Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Study of NXP900 With Lorlatinib in ALK+ Lung Cancer

NCT07784959

Conditions: ALK Positive, ALK Positive Non-small Cell Lung Cancer, ALK+ Non-Small-Cell Lung Carcinoma, +1 more
Locations: NEXT Virginia Fairfax, Virginia, United States

View Trial Details

Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric Field Ablation Devices in the Treatment of Lung Tumors

NCT06739031

Conditions: NSCLC
Locations: Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

View Trial Details

Recruiting

Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC

NCT07777822

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations: Florida Clinical Trials Group, LLC Plantation, Florida, United States

View Trial Details

Recruiting

Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer

NCT06457789

Conditions: NSCLC
Locations: Amsterdam UMC, location VUmc Amsterdam, North Holland, Netherlands

View Trial Details

Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

NCT07182149

Conditions: Adenocarcinoma Of Esophagus, Adnexal Diseases, Breast Diseases, +39 more
Locations: Normunity Investigational Site Denver, Colorado, United States

Normunity Investigational Site New Haven, Connecticut, United States

Normunity Investigational Site Minneapolis, Minnesota, United States

Normunity Investigational Site Maumee, Ohio, United States

View all 18 locations

View Trial Details

Recruiting

A Study to Assess the Efficacy and Safety of Firmonertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB - IIIB NSCLC With Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations, Following Complete Surgical Resection With or Without Adjuvant Chemotherapy（FIRMOST）

NCT07010419

Conditions: Adjuvant Treatment, NSCLC
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

Sun Yat-sen University Cancer Center Guangdong, Guangzhou, China

View Trial Details

Recruiting

SKB264 in Combination With SKB118 for Non-Small Cell Lung Cancer

NCT07697586

Conditions: NSCLC
Locations: Jilin Cancer Hospital Jilin City, China

Shanghai East Hospital, Tongji University Shanghai, China

View Trial Details

Recruiting

Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study

NCT07412041

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

NCT07397338

Conditions: Advanced Solid Tumors, Bronchial Neoplasms, CRC, +22 more
Locations: Eastern Connecticut Hematology and Oncology Associates Norwich, Connecticut, United States

Tennessee Oncology Nashville, Tennessee, United States

MD Anderson Cancer Center Houston, Texas, United States

NEXT Dallas Irving, Texas, United States

View Trial Details